Ortin Laboratories Limited

Total Valuation

Ortin Laboratories Limited carries a market capitalization of 165.31M, placing it among publicly traded companies globally. Its enterprise value stands at 188.35M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Valuation Ratios

Ortin Laboratories Limited trades at a trailing price-to-earnings ratio of 39.83.

Enterprise Valuation

On an enterprise value basis, Ortin Laboratories Limited trades at an EV/EBITDA multiple of 87.35 and an EV/FCF ratio of 39.99. The EV/Sales ratio of 5.50 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 87.35 provides insight into valuation relative to core operating earnings.

Financial Position

Ortin Laboratories Limited maintains a current ratio of 1.61, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 120.91, indicating elevated leverage, while an interest coverage ratio of -7.60 demonstrates limited ability to service its debt obligations.

Taxes

Stock Price Statistics

Ortin Laboratories Limited's stock has gained approximately 3.98977% over the past 52 weeks. The 50-day moving average sits at 20.24, while the 200-day moving average is 20.07.

Income Statement

Over the trailing twelve months, Ortin Laboratories Limited generated 34.23M in revenue and converted that into -41.00M in net income, yielding earnings per share of -5.03. EBITDA reached -35.84M, while operating income came in at -35.84M.

Margins

Ortin Laboratories Limited operates with a gross margin of -30.46, reflecting its pricing power and cost economics. The operating margin of -104.69 and net profit margin of -119.76 provide insight into operational efficiency.

Stock Splits

Ortin Laboratories Limited's most recent stock split took place on January 12, 2021 with a 25:12 split ratio.

Scores

Ortin Laboratories Limited posts an Altman Z-Score of 1.60, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.